Thiol-Containing Alkyl Fatty Acid Formulations for Metabolic Syndrome

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nutritional supplements are insufficient in addressing metabolic dysfunction, such as pre-diabetes and diabetes, due to the lack of bioavailability and temporal, spatial, and structural requirements of nutrients, leading to insulin resistance and metabolic disorders.

Innovation Solution

The development of alkyl fatty acid and vitamin D compound formulations that combine thiol-containing alkyl fatty acids, N-acetyl-L-carnitine derivatives, antioxidants, amino acids, and other botanical extracts to enhance glucose uptake and metabolic function, allowing for contemporaneous exposure to multiple components that improve bioavailability and reduce insulin resistance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If multiple nutritional supplements are administered separately to address metabolic dysfunction, then each nutrient can be delivered in theoretically adequate doses, but the bioavailability and temporal-spatial coordination of nutrients is insufficient, leading to poor therapeutic efficacy

Engineering Contradiction:
Improvedosage of individual nutrientsVSAvoidtherapeutic efficacy
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent combines multiple nutritional supplements (vitamins, minerals, amino acids, fatty acids, antioxidants, and herbal extracts) into a single integrated formulation. This merging ensures that all nutrients are delivered simultaneously in bioavailable forms with proper temporal-spatial coordination, resolving the contradiction between adequate dosing and therapeutic efficacy by ensuring both quantity and quality of nutrient delivery work together synergistically

Inventive Principle:
Principle #5Merging (Combining)

2Quantity of substance

If processed foods and supplements are used to replace missing nutrients, then nutrient replacement is achieved, but the complexity of metabolic coordination and bioavailability requirements cannot be met

Engineering Contradiction:
Improvenutrient replacementVSAvoidmetabolic coordination complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent creates a composite nutritional formulation that integrates multiple nutrient types (vitamins, minerals, amino acids, fatty acids, antioxidants, herbal extracts) in specific combinations. This composite approach simplifies the complexity of metabolic coordination by pre-coordinating all necessary nutrients in a single formulation that mimics the complex coordination found in whole foods, making nutrient replacement both effective and manageable

Inventive Principle:
Principle #40Composite materials

3Adaptability or versatility

If multiple individual supplements are taken to achieve comprehensive nutrient coverage, then all necessary nutrients can be provided, but the number of capsules or tablets required becomes impractical and increases filler intake

Engineering Contradiction:
Improvecomprehensive nutrient coverageVSAvoidcompliance practicality
Core Design Contradiction:
Adaptability or versatilityVSEase of operation

Solution Approach 1:

The patent merges multiple individual supplement products into a single comprehensive formulation that provides all necessary nutrients in one capsule or tablet. This eliminates the need for patients to take multiple separate supplements, dramatically improving compliance practicality while maintaining comprehensive nutrient coverage. The single formulation reduces filler intake and simplifies the daily routine for patients

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS11337960B2Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome
Publication Date: 2022.05.24 PRE-D PARTNERS LLC
  • US11337960B2 patent drawing
  • US11337960B2 patent drawing
  • US11337960B2 patent drawing

AI summary

The disclosure provides thiol-containing alkyl fatty acid compound formulations for intravenous, parenteral or oral administration. The compositions of the present technology have optimal controlled bioavailability and are useful for treating metabolic dysfunctions such as pre-diabetes, Metabolic Syndrome and diabetes. Also provided are methods of treatment comprising the daily administration of the disclosed thiol-containing alkyl fatty acid formulations.